Meridian Bioscience ROA 2006-2018 | VIVO

Current and historical return on assets (ROA) values for Meridian Bioscience (VIVO) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets. Meridian Bioscience ROA for the three months ending December 31, 2018 was 13.36%.
Meridian Bioscience ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2018-12-31 $0.03B $0.25B 9.90%
2018-09-30 $0.02B $0.25B 9.09%
2018-06-30 $0.02B $0.25B 9.50%
2018-03-31 $0.02B $0.26B 6.79%
2017-12-31 $0.02B $0.25B 8.41%
2017-09-30 $0.02B $0.25B 8.43%
2017-06-30 $0.02B $0.25B 8.01%
2017-03-31 $0.03B $0.25B 11.50%
2016-12-31 $0.03B $0.25B 11.43%
2016-09-30 $0.03B $0.25B 13.46%
2016-06-30 $0.04B $0.26B 15.87%
2016-03-31 $0.04B $0.26B 17.37%
2015-12-31 $0.04B $0.19B 19.83%
2015-09-30 $0.04B $0.18B 19.53%
2015-06-30 $0.04B $0.18B 19.69%
2015-03-31 $0.04B $0.18B 19.69%
2014-12-31 $0.04B $0.18B 19.69%
2014-09-30 $0.03B $0.18B 19.18%
2014-06-30 $0.04B $0.18B 19.75%
2014-03-31 $0.04B $0.18B 20.54%
2013-12-31 $0.04B $0.18B 20.90%
2013-09-30 $0.04B $0.18B 22.06%
2013-06-30 $0.04B $0.17B 22.60%
2013-03-31 $0.04B $0.17B 22.40%
2012-12-31 $0.04B $0.16B 22.68%
2012-09-30 $0.04B $0.16B 22.12%
2012-06-30 $0.03B $0.16B 21.05%
2012-03-31 $0.03B $0.16B 19.81%
2011-12-31 $0.03B $0.16B 17.92%
2011-09-30 $0.03B $0.16B 17.25%
2011-06-30 $0.03B $0.16B 15.97%
2011-03-31 $0.02B $0.16B 15.56%
2010-12-31 $0.02B $0.16B 15.03%
2010-09-30 $0.03B $0.16B 17.02%
2010-06-30 $0.03B $0.15B 19.61%
2010-03-31 $0.03B $0.15B 21.60%
2009-12-31 $0.03B $0.16B 22.48%
2009-09-30 $0.03B $0.16B 22.15%
2009-06-30 $0.03B $0.15B 21.84%
2009-03-31 $0.03B $0.15B 21.42%
2008-12-31 $0.03B $0.15B 21.60%
2008-09-30 $0.03B $0.15B 21.31%
2008-06-30 $0.03B $0.14B 20.36%
2008-03-31 $0.03B $0.14B 21.68%
2007-12-31 $0.03B $0.14B 21.71%
2007-09-30 $0.03B $0.13B 21.47%
2007-06-30 $0.03B $0.13B 21.18%
2007-03-31 $0.02B $0.12B 18.33%
2006-12-31 $0.02B $0.12B 17.95%
2006-09-30 $0.02B $0.12B 16.63%
2006-06-30 $0.02B $0.12B 16.11%
2006-03-31 $0.02B $0.11B 15.50%
2005-12-31 $0.01B $0.11B 14.62%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.698B $0.214B
Meridian Bioscience, Inc. is a fully integrated life science company that manufactures, markets and distributes a broad range of innovative diagnostic test kits, purified reagents and biopharmaceutical enabling technologies that help deliver answers. Its products provide accuracy, simplicity and speed for the early diagnosis and treatment of common medical conditions, such as C. difficile, H. pylori, foodborne diseases and respiratory infections. In addition, the company develops and manufactures a variety of biological and non-biological materials used in proficiency testing programs. Meridian diagnostic products are used outside of the human body and require little or no special equipment. Meridian Bioscience designs their products to enhance the well-being of the patient-while reducing the total outcome costs of healthcare. Meridian has strong market positions in the areas of gastrointestinal infections, serology, parasitology and fungal disease diagnosis.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $129.916B 25.68
Medtronic (MDT) Ireland $122.526B 18.32
Stryker (SYK) United States $69.144B 25.38
Boston Scientific (BSX) United States $55.241B 26.97
Baxter (BAX) United States $38.548B 23.75
Zimmer Biomet Holdings (ZBH) United States $24.985B 16.03
Smith & Nephew SNATS (SNN) United Kingdom $16.606B 0.00
ResMed (RMD) United States $14.250B 27.02
Canopy Growth (CGC) Canada $10.707B 0.00
Bio-Rad Laboratories (BIO) United States $7.832B 50.08
Aurora Cannabis (ACB) Canada $7.090B 50.71
Hill-Rom Holdings (HRC) United States $6.904B 21.35
Perrigo (PRGO) Ireland $6.603B 10.02
ICU Medical (ICUI) United States $5.119B 28.52
Insulet (PODD) United States $5.012B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $4.563B 0.00
Haemonetics (HAE) United States $4.395B 38.99
Agios Pharmaceuticals (AGIO) United States $3.341B 0.00
Hutchison China MediTech (HCM) China $3.330B 0.00
Neogen (NEOG) United States $3.259B 50.06
NuVasive (NUVA) United States $3.008B 27.99
National Vision Holdings (EYE) United States $2.570B 49.72
Quidel (QDEL) United States $2.529B 22.88
Aphria (APHA) $2.274B 101.00
NxStage Medical (NXTM) United States $1.945B 0.00
AtriCure (ATRC) United States $1.269B 0.00
VAREX IMAGING (VREX) United States $1.196B 23.42
Phibro Animal Health (PAHC) United States $1.192B 17.13
Cardiovascular Systems (CSII) United States $1.151B 826.00
HEXO (HEXO) $1.127B 0.00
MacroGenics (MGNX) United States $0.893B 0.00
Cerus (CERS) United States $0.848B 0.00
PetIQ (PETQ) United States $0.821B 21.28
Evolus (EOLS) United States $0.744B 0.00
Surmodics (SRDX) United States $0.724B 105.35
NanoString Technologies (NSTG) United States $0.721B 0.00
Lantheus Holdings (LNTH) United States $0.711B 22.00
OraSure Technologies (OSUR) United States $0.707B 31.19
Omeros (OMER) United States $0.703B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.604B 19.39
Quanterix (QTRX) United States $0.491B 0.00
LeMaitre Vascular (LMAT) United States $0.486B 23.89
Owens & Minor (OMI) United States $0.470B 5.32
TG Therapeutics (TGTX) United States $0.390B 0.00
Insys Therapeutics (INSY) United States $0.355B 0.00
Utah Medical Products (UTMD) United States $0.339B 21.98
BioLife Solutions (BLFS) United States $0.285B 385.00
Bovie Medical (APYX) United States $0.283B 0.00
Vapotherm (VAPO) United States $0.279B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.272B 0.00
Cytosorbents (CTSO) United States $0.256B 0.00
Rockwell Medical (RMTI) United States $0.228B 0.00
Zynex (ZYXI) United States $0.165B 15.97
Surface Oncology (SURF) United States $0.152B 0.00
Fonar (FONR) United States $0.147B 7.87
Chembio Diagnostics (CEMI) United States $0.120B 0.00
Chimerix (CMRX) United States $0.100B 0.00
United-Guardian (UG) United States $0.091B 19.11
Female Health (VERU) United States $0.086B 0.00
InfuSystems Holdings (INFU) United States $0.079B 0.00
CAS Medical Systems (CASM) United States $0.070B 0.00
Trinity Biotech (TRIB) Ireland $0.063B 17.53
Conatus Pharmaceuticals (CNAT) United States $0.061B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.056B 0.00
ImmuCell (ICCC) United States $0.040B 0.00
Neurotrope (NTRP) United States $0.033B 0.00
Senestech (SNES) United States $0.020B 0.00
Myomo (MYO) United States $0.016B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.013B 0.00
Capricor Therapeutics (CAPR) United States $0.013B 0.00
Akers Biosciences Inc (AKER) United States $0.011B 0.00
Valeritas Holdings (VLRX) United States $0.010B 0.00
Cellectar Biosciences (CLRB) United States $0.009B 0.00
NeuroMetrix (NURO) United States $0.008B 14.14